Genomic Architecture of Progression and Treatment Response in AMD
Demographics (6)
- AGE - Age at baseline exam (phv00259034.v1.p1)
- AGE - Age at qualifying exam (eyes determined to be > AREDS grade 5 bilaterally) (phv00259038.v1.p1)
- AGE - Age at most recent exam (phv00259042.v1.p1)
- SEX - Gender of participant (phv00259035.v1.p1)
- SEX - Gender of participant (phv00259039.v1.p1)
- SEX - Gender of participant (phv00259043.v1.p1)
General Health (4)
- AFFECTION_STATUS - Case (AMD) - control status of the subject (phv00259025.v1.p1)
- PHENO_STATUS - AMD Case/control status (phv00259030.v1.p1)
- PHENO_STATUS - Phenotype (AMD status) (phv00259037.v1.p1)
- PHENO_STATUS - Phenotype (AMD status) (phv00259041.v1.p1)
Other (18)
- ANALYTE_TYPE - Analyte Type (phv00259046.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00259045.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00259024.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00259047.v1.p1)
- PROGRESSION_STATUS - Progression rate status (phv00259032.v1.p1)
- SAMPLE_ID - Sample ID (phv00259027.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00259044.v1.p1)
- SAMPLE_SOURCE - Sample source (phv00386908.v1.p1)
- SAMPLE_USE - Sample Use (phv00259028.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00259048.v1.p1)
- SOURCE_SAMPLE_ID - Sample ID at source (phv00386909.v1.p1)
- STUDY - Progression or treatment dataset (phv00259031.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00259029.v1.p1)
- SUBJECT_ID - Subject ID (phv00259026.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00259036.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00259040.v1.p1)
- SUBJECT_ID - Subject ID (phv00259023.v1.p1)
- TREATMENT_STATUS - Treatment response status (both eyes where available) (phv00259033.v1.p1)